Literature DB >> 21135577

The RP-p53-Mdm2 pathway: a new link to genetic integrity?

Rebeca A Frum, Yanping Zhang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21135577      PMCID： PMC3233472          DOI： 10.4161/cc.9.22.13606

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  55 in total

Review 1.  Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway.

Authors:  C Deisenroth; Y Zhang
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

2.  A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

Authors:  Alexander Roesch; Mizuho Fukunaga-Kalabis; Elizabeth C Schmidt; Susan E Zabierowski; Patricia A Brafford; Adina Vultur; Devraj Basu; Phyllis Gimotty; Thomas Vogt; Meenhard Herlyn
Journal:  Cell       Date:  2010-05-14       Impact factor: 41.582

3.  Human ELG1 regulates the level of ubiquitinated proliferating cell nuclear antigen (PCNA) through Its interactions with PCNA and USP1.

Authors:  Kyoo-Young Lee; Kailin Yang; Martin A Cohn; Nilabja Sikdar; Alan D D'Andrea; Kyungjae Myung
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

4.  Cancer: miRNA addiction - depending on life's little things.

Authors:  David Dornan; Jeff Settleman
Journal:  Curr Biol       Date:  2010-09-28       Impact factor: 10.834

5.  Rfc5p regulates alternate RFC complex functions in sister chromatid pairing reactions in budding yeast.

Authors:  Marie E Maradeo; Anisha Garg; Robert V Skibbens
Journal:  Cell Cycle       Date:  2010-11-13       Impact factor: 4.534

6.  p53-dependent repression of polo-like kinase-1 (PLK1).

Authors:  Lynsey McKenzie; Sharon King; Lynnette Marcar; Sam Nicol; Sylvia S Dias; Katie Schumm; Pamela Robertson; Jean-Christophe Bourdon; Neil Perkins; Frances Fuller-Pace; David W Meek
Journal:  Cell Cycle       Date:  2010-10-04       Impact factor: 4.534

7.  Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway.

Authors:  Susana Llanos; Manuel Serrano
Journal:  Cell Cycle       Date:  2010-10-09       Impact factor: 4.534

8.  Chemotherapeutic drugs inhibit ribosome biogenesis at various levels.

Authors:  Kaspar Burger; Bastian Mühl; Thomas Harasim; Michaela Rohrmoser; Anastassia Malamoussi; Mathias Orban; Markus Kellner; Anita Gruber-Eber; Elisabeth Kremmer; Michael Hölzel; Dirk Eick
Journal:  J Biol Chem       Date:  2010-02-16       Impact factor: 5.157

Review 9.  The promise of microRNA replacement therapy.

Authors:  Andreas G Bader; David Brown; Matthew Winkler
Journal:  Cancer Res       Date:  2010-08-31       Impact factor: 12.701

10.  Non-redundant role for the transcription factor Gli1 at multiple stages of thymocyte development.

Authors:  Ekati Drakopoulou; Susan V Outram; Nicola J Rowbotham; Susan E Ross; Anna L Furmanski; Jose Ignacio Saldana; Ariadne L Hager-Theodorides; Tessa Crompton
Journal:  Cell Cycle       Date:  2010-10-27       Impact factor: 4.534
View more
  1 in total

Review 1.  Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Authors:  Wei Wang; Subhasree Nag; Xu Zhang; Ming-Hai Wang; Hui Wang; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2014-08-28       Impact factor: 12.944
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.